SCHEMBL21798643

SCHEMBL21798643

Cc1cccc2cc3c(=O)n(-c4ccc(F)cc4)cc(C(=O)NCC(C)N(C)CC(C)C)c3nc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLR1A O95602 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
RECQL P46063 1/20 0.36
PDE4A P27815 1/20 0.35
KCNH2 Q12809 1/20 0.35
KDM4E B2RXH2 3/20 0.35
LMNA P02545 2/20 0.35
ATM Q13315 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TP53 P04637 7/20 0.34
MAPT P10636 4/20 0.34
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21798648 0.88 KMT2A (0.41) KMT2AMEN1L3MBTL1RECQLKDM4E
SCHEMBL21798641 0.86 KMT2A (0.38) KMT2AMEN1L3MBTL1RECQLPDE4A
SCHEMBL4105365 0.84 RAD52 (0.44) POLR1AKMT2AMEN1L3MBTL1RECQL
SCHEMBL21798647 0.83 MEN1 (0.43) POLR1AKMT2AMEN1L3MBTL1RECQL
SCHEMBL21798661 0.82 MEN1 (0.39) KMT2AMEN1KDM4ELMNAALDH1A1
SCHEMBL21798674 0.81 MEN1 (0.36) KMT2AMEN1L3MBTL1KCNH2KDM4E
SCHEMBL21798683 0.81 AHR (0.41) KMT2AMEN1L3MBTL1RECQLKDM4E
SCHEMBL21798640 0.80 MEN1 (0.41) KMT2AMEN1KDM4ELMNAALDH1A1
SCHEMBL21798659 0.78 MEN1 (0.39) KMT2AMEN1KDM4ELMNAALDH1A1
SCHEMBL634259 0.78 KDM4E (0.55) KMT2AMEN1L3MBTL1RECQLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046687-B2 Polycyclic amide compound, preparation process and use thereof HEBEI GRANDIOS PHARMA CO., LTD. 2021-06-29 US disclosed
US-20200079771-A1 Novel Polycyclic Amide Compound, Preparation Process And Use Thereof HEBEI GRANDIOS PHARMA CO., LTD. (CN) 2020-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200079771-A1 Novel Polycyclic Amide Compound, Preparation Process And Use Thereof H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-0, UACA POLR1A 373/4885KMT2A 2396/4885MEN1 936/4885
US-11046687-B2 Polycyclic amide compound, preparation process and use thereof H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, UACA, H1-0 POLR1A 500/4885KMT2A 2477/4885MEN1 694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.